Leonard G. Gomella

Research interests

Publications

• The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(21)01790-6

• Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

  The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30540-4

• Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

  Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.20.00046

• Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.74.1173

• Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs

  Proceedings of the National Academy of Sciences · 2015 · https://doi.org/10.1073/pnas.1420955112

• Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.59.0026

• Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling and Specimen Processing

  The Journal of Urology · 2013 · https://doi.org/10.1016/j.juro.2013.02.072

• Dual Roles of PARP-1 Promote Cancer Growth and Progression

  Cancer Discovery · 2012 · https://doi.org/10.1158/2159-8290.cd-12-0120

• Effect of Dutasteride on the Risk of Prostate Cancer

  New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0908127

• The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

  Journal of Clinical Investigation · 2010 · https://doi.org/10.1172/jci44239

• MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

  The Journal of Pathology · 2009 · https://doi.org/10.1002/path.2586

• Micro-RNA profiling in kidney and bladder cancers

  Urologic Oncology Seminars and Original Investigations · 2007 · https://doi.org/10.1016/j.urolonc.2007.01.019

• A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study

  The Journal of Urology · 2007 · https://doi.org/10.1016/j.juro.2007.03.028

• A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer

  The Journal of Urology · 2007 · https://doi.org/10.1016/j.juro.2007.03.034

• Circulating tumor cells predict survival in patients with metastatic prostate cancer

  Urology · 2005 · https://doi.org/10.1016/j.urology.2004.11.006

• CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

  The Journal of Urology · 2004 · https://doi.org/10.1097/01.ju.0000139320.78673.2a

• Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.

  Journal of Clinical Oncology · 1997 · https://doi.org/10.1200/jco.1997.15.9.3156

• Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1.

  PubMed · 1993

• Detection of hematogenous micrometastasis in patients with prostate cancer.

  PubMed · 1992

Current projects

No projects listed.